104 related articles for article (PubMed ID: 15179824)
21. Contributions of individual residues in the N-terminal region of cystatin B (stefin B) to inhibition of cysteine proteinases.
Pol E; Björk I
Biochim Biophys Acta; 2003 Jan; 1645(1):105-12. PubMed ID: 12535617
[TBL] [Abstract][Full Text] [Related]
22. Cystatin B as an intracellular modulator of bone resorption.
Laitala-Leinonen T; Rinne R; Saukko P; Väänänen HK; Rinne A
Matrix Biol; 2006 Apr; 25(3):149-57. PubMed ID: 16321512
[TBL] [Abstract][Full Text] [Related]
23. Cysteine cathepsins B and L and their inhibitors stefins A and B in carcinoma of the oropharynx: immunohistochemical study.
Strojan P; Oblak I; Gale N; Smid L; Kos J
Histopathology; 2008 Nov; 53(5):612-4. PubMed ID: 18983473
[No Abstract] [Full Text] [Related]
24. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells.
Colella R; Casey SF
Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846
[TBL] [Abstract][Full Text] [Related]
25. [The lysosomal cathepsins B, L and D in development of murine experimental leukemias].
Khalikova TA; Korolenko TA; Il'nitskaia SI
Biomed Khim; 2009; 55(5):621-34. PubMed ID: 20017393
[TBL] [Abstract][Full Text] [Related]
26. Presence of anti-cystatin C-positive dendritic cells or macrophages and localization of cysteine proteases in the apical bud of the enamel organ in the rat incisor.
Nishikawa S
J Histochem Cytochem; 2005 May; 53(5):643-51. PubMed ID: 15872057
[TBL] [Abstract][Full Text] [Related]
27. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases.
Pol E; Björk I
Biochemistry; 1999 Aug; 38(32):10519-26. PubMed ID: 10441148
[TBL] [Abstract][Full Text] [Related]
28. Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases.
Lenarcic B; Krizaj I; Zunec P; Turk V
FEBS Lett; 1996 Oct; 395(2-3):113-8. PubMed ID: 8898076
[TBL] [Abstract][Full Text] [Related]
29. Regulation of activity of cathepsins B, L, and D in murine lymphosarcoma model at a combined treatment with cyclophosphamide and yeast polysaccharide.
Khalikova TA; Zhanaeva SY; Korolenko TA; Kaledin VI; Kogan G
Cancer Lett; 2005 Jun; 223(1):77-83. PubMed ID: 15890239
[TBL] [Abstract][Full Text] [Related]
30. Cystatins and cathepsins in breast carcinoma.
Lah TT; Kokalj-Kunovar M; Drobnic-Kosorok M; Babnik J; Golouh R; Vrhovec I; Turk V
Biol Chem Hoppe Seyler; 1992 Jul; 373(7):595-604. PubMed ID: 1515089
[TBL] [Abstract][Full Text] [Related]
31. Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines.
Zajc I; Sever N; Bervar A; Lah TT
Cancer Lett; 2002 Dec; 187(1-2):185-90. PubMed ID: 12359367
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin L is capable of truncating cystatin C of 11 N-terminal amino acids.
Popovic T; Cimerman N; Dolenc I; Ritonja A; Brzin J
FEBS Lett; 1999 Jul; 455(1-2):92-6. PubMed ID: 10428479
[TBL] [Abstract][Full Text] [Related]
33. Cystatin C and cysteine proteinases during the development and therapy of Lewis lung adenocarcinoma in mice.
Usova TA; Poteryaeva ON; Zhanayeva SY; Yarygina ES; Korolenko TA
Bull Exp Biol Med; 2003 Jan; 135(1):81-4. PubMed ID: 12717521
[TBL] [Abstract][Full Text] [Related]
34. Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.
Heidtmann HH; Salge U; Abrahamson M; Bencina M; Kastelic L; Kopitar-Jerala N; Turk V; Lah TT
Clin Exp Metastasis; 1997 Jul; 15(4):368-81. PubMed ID: 9219725
[TBL] [Abstract][Full Text] [Related]
35. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors.
Turk B; Turk V; Turk D
Biol Chem; 1997; 378(3-4):141-50. PubMed ID: 9165064
[TBL] [Abstract][Full Text] [Related]
36. Effect of vitamin E and human placenta cysteine peptidase inhibitor on expression of cathepsins B and L in implanted hepatoma Morris 5123 tumor model in Wistar rats.
Sebzda T; Hanczyc P; Saleh Y; Akinpelumi BF; Siewinski M; Rudnicki J
World J Gastroenterol; 2005 Jan; 11(4):587-92. PubMed ID: 15641152
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells.
Chambers AF; Colella R; Denhardt DT; Wilson SM
Mol Carcinog; 1992; 5(3):238-45. PubMed ID: 1586450
[TBL] [Abstract][Full Text] [Related]
38. Distribution, activity and concentration of cathepsin B and cystatin C in the wall of aortic aneurysm.
Gacko M; Chyczewski L; Chrostek L
Pol J Pathol; 1999; 50(2):83-6. PubMed ID: 10481531
[TBL] [Abstract][Full Text] [Related]
39. Interactions between ovine cathepsin L, cystatin C and alpha 2-macroglobulin. Potential role in the genital tract.
Peloille S; Esnard A; Dacheux JL; Guillou F; Gauthier F; Esnard F
Eur J Biochem; 1997 Feb; 244(1):140-6. PubMed ID: 9063457
[TBL] [Abstract][Full Text] [Related]
40. Enhancing effect of new biological response modifier sulfoethylated (1-->3)-beta-D-glucan on antitumor activity of cyclophosphamide in the treatment of experimental murine leukoses.
Khalikova TA; Korolenko TA; Zhanaeva SY; Kaledin VI; Kogan G
Exp Oncol; 2006 Dec; 28(4):308-13. PubMed ID: 17285116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]